CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
ConditionAtopic Dermatitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age10-15
SponsorCorEvitas
About this trial
Prospective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.
Eligibility criteria
Qualifiers
Has been diagnosed with moderate to severe atopic dermatitis by a dermatologist or a qualified healthcare provider
Is 10 - 15 years of age at the time of enrollment.
Subject has initiated or is initiating an enrollment-eligible medication at the time of enrollment
Disqualifiers
Is participating or planning to participate in a blinded clinical trial for an AD drug.
Is unwilling or unable to provide standing height measurements.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov